View Cart (0 items)
Pharmaceutical

FDA: Bayer must update Yaz warning labels

December 14, 2011
/ Print / Reprints /
| Share More
/ Text Size+

EAST ST. LOUIS, Mo. — An independent FDA panel has voted 21-5 to require Bayer AG to update warning labels on its popular birth control Yaz to reflect new concerns regarding the drug’s safety, according to a press release.

The decision comes in light of recent studies that suggest new contraceptives containing the hormone drospirenone may be more dangerous than older drugs.

The panel, comprised of independent medical experts, has also called for additional studies on birth controls to further evaluate drospirenone’s increased risk of causing blood clots that can result in serious medical events such as strokes, heart attacks and even death.
You must login or register in order to post a comment.